Clarius Group LLC’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $324K | Buy |
|
|||||
|
2025
Q2 | $169K | Sell |
|
|||||
|
2025
Q1 | $215K | Hold |
|
|||||
|
2024
Q4 | $255K | Hold |
|
|||||
|
2024
Q3 | $551K | Hold |
|
|||||
|
2024
Q2 | $579K | Hold |
|
|||||
|
2024
Q1 | $890K | Hold |
|
|||||
|
2023
Q4 | $774K | Hold |
|
|||||
|
2023
Q3 | $587K | Hold |
|
|||||
|
2023
Q2 | $1.27M | Buy |
|
|||||
|
2023
Q1 | $38.7K | Hold |
|
|||||
|
2022
Q4 | $57K | Hold |
|
|||||
|
2022
Q3 | $120K | Hold |
|
|||||
|
2022
Q2 | $107K | Hold |
|
|||||
|
2022
Q1 | $127K | Hold |
|
|||||
|
2021
Q4 | $127K | Buy |
|